AzTrials
AzTrials

Healthy AgingAACSNCT05908487

African Americans (AA) Communities Speak

A study testing AA Communities Speak to Healthcare Professionals in people with Healthy Aging and Health Knowledge, Attitudes, Practice, run by University of Alabama at Birmingham at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

African Americans are less likely to receive quality end-of-life (EoL) care. Addressing disparities in EoL care will need efforts to support a better understanding of African American patients' EoL cultural values and preferences for EoL communication and the impact of historical and ongoing care delivery inequities… Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
AA Communities Speak to Healthcare Professionals
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesUnited States
Study dates
27 Feb 2025to Jul 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Person with serious Illness:
  • Self-identified as African American (i.e., born, raised, and lived primarily in the US)
  • Non-Hispanic or Latino
  • Age ≥60 years
  • English-speaking
  • Has been diagnosed with a condition that fits into one of 3 illness paradigms including cancer, cardiac disease, pulmonary disease, neuro-degenerative disease, renal disease, stroke, sepsis, hepatic disease)
Show all 31Show fewer
  • Callahan Six-Item Screener score ≥4
  • Able to complete baseline surveys.
  • Bereaved family member:
  • Self-identified as African American (i.e., born, raised, and lived primarily in the US)
  • Non-Hispanic or Latino
  • Age ≥60 years
  • English-speaking
  • Loved one dies in the last 12 months and was diagnosed with a condition that fits into one of 3 illness paradigms including cancer, cardiac disease, pulmonary disease, neuro- degenerative disease, renal disease, stroke, sepsis, hepatic disease)
  • Callahan Six-Item Screener score ≥4
  • Able to complete baseline surveys.
  • Bereaved Family member:
  • Self-identified as African American (i.e., born, raised, and lived primarily in the US)
  • Non-Hispanic or Latino
  • Age ≥60 years
  • English-speaking
  • Loved one dies in the last 12 months and was diagnosed with a condition that fits into one of 3 illness paradigms including cancer, cardiac disease, pulmonary disease, neuro- degenerative disease, renal disease, stroke, sepsis, hepatic disease)
  • Callahan Six-Item Screener score ≥4
  • Able to complete baseline surveys
  • Pastors:
  • Self-identifying as African American
  • White, Non-Hispanic or Latino
  • Sged ≥18 years old.
  • Clinician eligibility:
  • Practice at a University of Alabama at Birmingham (UAB) or Montefiore/Einstein site that provides care to patients eligible for outcomes surveys
  • At least 3 months of clinical practice at the study site prior to the intervention training to measure pre-intervention patient surveys

Who cannot join

  • Person with serious illness:
  • -Cannot be receiving hospice care
  • Bereaved Family Member:
  • -Cannot be a paid "sitter"
  • -Lack of at least 3 months of clinical practice at the study site prior to the intervention training.
  • Patient eligibility:
Show all 18Show fewer
  • Self-identified as African American (i.e., born, raised, and lived primarily in the US)
  • Non-Hispanic or Latino, 3. age ≥60 years
  • English-speaking
  • Has been diagnosed with a condition that fits into one of 3 illness paradigms including cancer, cardiac disease, pulmonary disease, neuro-degenerative disease, renal disease, stroke, sepsis, hepatic disease)
  • Callahan Six-Item Screener score ≥4
  • Able to complete baseline surveys.
  • -Currently receiving hospice care.
  • Family member eligibility:
  • Age ≥ 18 years
  • English-speaking
  • Community-dwelling
  • Unpaid care provider of a person with a serious illness.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Ronit Elk, PhD contact

205.996.1702

relk@uabmc.edu

Tametria V Heard, PhD contact

205.934.7905

tvheard@uabmc.edu

United States2 sites, 2 recruiting
  • UAB

    Birmingham, Alabama, 35233

    Ronit Elk, PhD, 205.996.1702, relk@uabmc.edu

    Tametria Heard, PhD, 205.934.7905, tvheard@uabmc.edu

    Recruiting
  • Albert Einstein/Montefiore

    The Bronx, New York, 10461

    Elizabeth Chuang, MD, 718-920-4630, Echuang@montefiore.org

    Elizabeth Chuang, MD

    Recruiting

Other trials in United States

About this study

Official title: African Americans (AA) Communities Speak: Partnering With AA in the North and South to Train Palliative Care Clinicians to Address Interpersonal and Systemic Racism and Provide Culturally Aligned Care.

African Americans are less likely to receive quality end-of-life (EoL) care. Addressing disparities in EoL care will need efforts to support a better understanding of African American patients' EoL cultural values and preferences for EoL communication and the impact of historical and ongoing care delivery inequities in healthcare settings.

Our proposed "Caring for Older African Americans" training program is designed to empower clinicians to improve goal-concordant EoL care delivery by using community-developed storytelling videos to create empathy with experiences of racism in EoL care, guidelines for culturally concordant EoL care delivery, and an implicit bias recognition and management training to mitigate bias in goals of care communication.

Read the detailed description

African Americans (AA) are less likely to receive quality end-of-life (EoL) care. For example, goals of care conversations, which are critical discussions between clinicians, patients, and families near the end of life, are less likely to occur for AAs than for Whites, and preferences are less likely to be followed when they do occur. Instead, families are more likely to be labeled as "difficult" if their decisions are incongruent with clinicians' recommendations. EoL decisions for many AA persons are rooted in both culture and a lifetime of experiences of structural racism. Efforts to address disparities need to address multiple factors such as patient-level cultural identity and EoL care values, interpersonal- and community-level norms for EoL communication and treatment, and healthcare institutional contexts for delivering EoL care in a setting affected by institutional racism.

Our research group began to address this need with 'African American Community Speaks', a proof-of-concept prototype of a community-developed training program for clinicians caring for AA older adults with serious illnesses. The program originally focused on rural Southern older AAs and is not broadly generalizable across the US due to geographic differences in culture, attitudes, and communication preferences among AA persons in the US. Thus, we propose to adapt our prototype program to urban-dwelling Southern and Northern older AA adults using our established platform of Community-Based Participatory Research (CBPR) in two geographically diverse regions: Birmingham, Alabama, and the Bronx, New York. To create the new training program called 'Caring for Older African Americans', our team of experts in CBPR, medical sociology, and clinical trials will work with local Community Advisory Boards to: 1. Conduct a comparative ethnographic study of urban dwelling AAs in the North and South to describe AA community values and preferences related to EoL care; 2. Adaptation of our prior community-developed training program by integrating community-developed storytelling videos for empathizing with experiences of racism in EoL care, guidelines for culturally concordant EoL care delivery, and adapting an existing implicit bias management program to goals of care communication; and 3. Conduct a cluster randomized trial in which we will randomize training times to 1 of 4 start dates using a stepped wedge design to accommodate the training of all clinicians and to mitigate the effect of secular trends.

Patients' personal experience of racism will be measured using the discrimination subscale of the Group Based Mistrust Scale. The primary outcome will be patient/family's perception of therapeutic alliance using The Human Connection Scale. Secondary outcomes will be family-reported goal-concordant care, and clinicians' knowledge of cultural values, awareness of implicit bias, and confidence to change practice. This innovative effort will be the first training program that: 1. addresses culturally concordant care, systemic racism, and implicit bias management, the three key elements in enhancing the provision of equitable care; and 2. is designed and implemented in full partnership with two distinct AA communities in the South and the North of the US.

Being tested
AA Communities Speak to Healthcare Professionals
Keywords
goal concordant care older African American CBPR end-of-life
Medical subject headings
Behavior, Systemic Racism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AA Communities Speak to Healthcare ProfessionalsBehavioural

    Also called Clinician Training

    The training program is designed to empower clinicians to improve goal-concordant EoL care delivery by using community-developed storytelling videos to create empathy with experiences of racism in EoL care, guidelines for culturally concordant EoL care delivery, and implicit bias recognition and management training to mitigate bias in goals of care communication.

Study groups in NCT05908487
Study groupRoleWhat they receive
Clinician Trainees- Cluster 1OtherWithin each participating institution, clinician clusters are randomized to 1 of 4 start date training times for the African American Communities Speak (AACS) Education Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period.
Receives: Behavioral: AA Communities Speak to Healthcare Professionals
Clinician Trainees- Cluster 2OtherWithin each participating institution, clinician clusters are randomized to 1 of 4 start date training times for the African American Communities Speak (AACS) Education Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period
Receives: Behavioral: AA Communities Speak to Healthcare Professionals
Clinician Trainees- Cluster 3OtherWithin each participating institution, clinician clusters are randomized to 1 of 4 start date training times for the African American Communities Speak (AACS) Education Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period
Receives: Behavioral: AA Communities Speak to Healthcare Professionals
Clinician Trainees- Cluster 4OtherWithin each participating institution, clinician clusters are randomized to 1 of 4 start date training times for the African American Communities Speak (AACS) Education Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period
Receives: Behavioral: AA Communities Speak to Healthcare Professionals

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Human Connection Scale (patient/family reported)

    The Human Connection (THC) Scale is a summary score of item responses such that a higher total score indicates greater therapeutic alliance. Possible scores range from 16 to 64. The 16-item THC scale had a high degree of internal consistency (Cronbach α= 90).

    Measured: up to 3 months before the intervention

  2. Human Connection Scale (patient/ family reported)

    The Human Connection (THC) Scale is a summary score of item responses such that a higher total score indicates greater therapeutic alliance. Possible scores range from 16 to 64. The 16-item THC scale had a high degree of internal consistency (Cronbach α= 90).

    Measured: up to 3 months after intervention

Secondary outcomes (2)
  1. Goal Concordant Care (patient/family reported)

    Goal Concordant Care will be measured based on responses to the following two questions, each with a dichotomous outcome: 1. Family member reports that the patient's end-of-life wishes were adequately discussed with the family respondent 2. Family member's satisfaction that patient's end-of-life were met.

    Johnson, S.B., Butow, P.N., Bell, M.L. et al. A randomized controlled trial of an advance care planning intervention for patients with incurable cancer. Br J Cancer 119, 1182-1190 (2018).

    https://doi.org.10.1038/s41416-018-0303-7

    Measured: up to 3 months before the intervention

  2. Goal Concordant Care (patient/family reported)

    Goal Concordant Care will be measured based on responses to the following two questions, each with a dichotomous outcome: 1. Family member reports that the patient's end-of-life wishes were adequately discussed with the family respondent 2. Family member's satisfaction that patient's end-of-life were met.

    Johnson, S.B., Butow, P.N., Bell, M.L. et al. A randomized controlled trial of an advance care planning intervention for patients with incurable cancer. Br J Cancer 119, 1182-1190 (2018).

    https://doi.org.10.1038/s41416-018-0303-7

    Measured: up to 3 months after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2023
  2. Study start27 Feb 2025
  3. Primary completionJul 2027 (estimated)
  4. Study completionJul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05908487
Sponsor's protocol ID
IRB300007677
Other IDs
R01AG078255
Acronym
AACS
Status last verified
May 2026
First submitted
1 Jun 2023
Last updated
7 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing AA Communities Speak to Healthcare Professionals in people with Healthy Aging and Health Knowledge, Attitudes, Practice, run by University of Alabama at Birmingham at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 31 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ronit Elk, PhD (205.996.1702, relk@uabmc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Human Connection Scale (patient/family reported) (time frame: up to 3 months before the intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2026; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in